These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9798083)

  • 1. Novel antipsychotics and new onset diabetes.
    Wirshing DA; Spellberg BJ; Erhart SM; Marder SR; Wirshing WC
    Biol Psychiatry; 1998 Oct; 44(8):778-83. PubMed ID: 9798083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
    Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
    J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of novel antipsychotics on glucose and lipid levels.
    Wirshing DA; Boyd JA; Meng LR; Ballon JS; Marder SR; Wirshing WC
    J Clin Psychiatry; 2002 Oct; 63(10):856-65. PubMed ID: 12416594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes as a result of atypical anti-psychotic drugs--a report of three cases.
    Rigalleau V; Gatta B; Bonnaud S; Masson M; Bourgeois ML; Vergnot V; Gin H
    Diabet Med; 2000 Jun; 17(6):484-6. PubMed ID: 10975220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics and hyperglycaemia.
    Mir S; Taylor D
    Int Clin Psychopharmacol; 2001 Mar; 16(2):63-73. PubMed ID: 11236071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes mellitus induced by olanzapine. A case report].
    Rojas P; Arancibia P; Bravo V; Varela S
    Rev Med Chil; 2001 Oct; 129(10):1183-5. PubMed ID: 11775346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine-induced glucose dysregulation.
    Bettinger TL; Mendelson SC; Dorson PG; Crismon ML
    Ann Pharmacother; 2000; 34(7-8):865-7. PubMed ID: 10928397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical neuroleptics and diabetes.
    Béliard S; Valero R; Vialettes B
    Diabetes Metab; 2003 Jun; 29(3):296-9. PubMed ID: 12909819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose intolerance with atypical antipsychotics.
    Hedenmalm K; Hägg S; Ståhl M; Mortimer O; Spigset O
    Drug Saf; 2002; 25(15):1107-16. PubMed ID: 12452735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight gain associated with antipsychotic drugs.
    Ganguli R
    J Clin Psychiatry; 1999; 60 Suppl 21():20-4. PubMed ID: 10548138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Type 2 diabetes and dyslipidemia. Side effects of "Atypical" neuroleptics?].
    Wetterling T
    Med Klin (Munich); 2003 Jul; 98(7):364-7. PubMed ID: 12937901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical issues associated with maintenance treatment of patients with schizophrenia.
    Guthrie SK
    Am J Health Syst Pharm; 2002 Sep; 59(17 Suppl 5):S19-24. PubMed ID: 12227083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia associated with the use of atypical antipsychotics.
    Lindenmayer JP; Nathan AM; Smith RC
    J Clin Psychiatry; 2001; 62 Suppl 23():30-8. PubMed ID: 11603883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia from olanzapine treatment in adolescents.
    Bloch Y; Vardi O; Mendlovic S; Levkovitz Y; Gothelf D; Ratzoni G
    J Child Adolesc Psychopharmacol; 2003; 13(1):97-102. PubMed ID: 12804130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-onset diabetes and ketoacidosis with atypical antipsychotics.
    Wilson DR; D'Souza L; Sarkar N; Newton M; Hammond C
    Schizophr Res; 2003 Jan; 59(1):1-6. PubMed ID: 12413635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priapism associated with conventional and atypical antipsychotic medications: a review.
    Compton MT; Miller AH
    J Clin Psychiatry; 2001 May; 62(5):362-6. PubMed ID: 11411819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglycemia associated with olanzapine.
    Fertig MK; Brooks VG; Shelton PS; English CW
    J Clin Psychiatry; 1998 Dec; 59(12):687-9. PubMed ID: 9921705
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
    Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
    Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.